HNRNPLL:新发现的结直肠癌转移抑制因子,在上皮-间质转化过程中调节CD44的选择性剪接
本研究通过全基因组shRNA文库筛选,鉴定出编码前体mRNA剪接因子的Hnrnpll为候选转移抑制基因。敲低Hnrnpll可增强结肠癌细胞的基质胶侵袭活性及体内转移能力,其机制与结合Cd44前体mRNA并增加Cd44v6水平有关。临床样本免疫组化显示,侵袭前沿E-钙黏蛋白低表达的结直肠癌细胞中HNRNPLL表达降低。
要点
- 全基因组shRNA文库筛选鉴定Hnrnpll为结直肠癌候选转移抑制基因。
- 敲低Hnrnpll增强结肠癌细胞体外基质胶侵袭活性及体内转移能力。
- HNRNPLL结合Cd44前体mRNA,敲低后Cd44v6水平升高,中和Cd44v6抗体抑制侵袭。
核心结论
- HNRNPLL是结直肠癌的新型转移抑制因子,并在上皮-间质转化过程中调节CD44的选择性剪接。
研究设计与样本
- 将转移活性差的小鼠直肠癌细胞系CMT93转导慢病毒shRNA文库后,移植入同基因C57BL/6小鼠直肠。
- 从转移灶收集基因组DNA,通过PCR回收整合的shRNA并测序,鉴定shRNA靶向的候选基因。
主要发现
- 全基因组shRNA文库筛选鉴定出编码前体mRNA剪接因子的Hnrnpll为候选转移抑制基因。
- 敲低Hnrnpll增强结肠癌细胞体外基质胶侵袭活性及体内转移能力。
- RNA免疫沉淀分析显示Hnrnpll结合Cd44前体mRNA,敲低Hnrnpll后Cd44可变外显子6(Cd44v6)水平升高。
- 中和性Cd44v6抗体抑制由Hnrnpll敲低诱导的基质胶侵袭能力。
- 结肠癌细胞被诱导发生上皮-间质转化时HNRNPLL表达下调;临床样本免疫组化显示侵袭前沿E-钙黏蛋白低表达的结直肠癌细胞HNRNPLL表达降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite the recent advances in treatment of colon cancer, the prognosis is unfavourable for patients with distant metastases. The aim of this study was to identify targets for prevention and/or therapy of colon cancer metastasis. DESIGN: CMT93 cells, a murine rectal cancer cell line with poor metastasising activity, were transduced with lentiviral shRNA library and transplanted into the rectum of syngeneic C57BL/6 mice. Genomic DNA was collected from metastatic lesions, and the integrated shRNA were retrieved by PCR for sequencing, followed by identification of the candidate genes targeted by the shRNA. RESULTS: The genome-wide shRNA library screen identified Hnrnpll (heterogeneous nuclear ribonucleoprotein L-like) encoding a pre-mRNA splicing factor as a candidate metastasis suppressor gene. Knockdown of Hnrnpll enhanced matrigel invasion activity of colon cancer cells in vitro, as well as their metastatic ability in vivo. An RNA-immunoprecipitation analysis showed Hnrnpll-binding to Cd44 pre-mRNAs, and the level of Cd44 variable exon 6 (Cd44v6), a poor prognosis marker of colorectal cancer, was increased by knocking down Hnrnpll. A neutralising Cd44v6 antibody suppressed the matrigel invasion ability induced by Hnrnpll knockdown. HNRNPLL expression was downregulated when colon cancer cells were induced to undergo epithelial-mesenchymal transition (EMT). Immunohistochemistry of clinical samples indicated that colorectal cancer cells with low E-cadherin expression at the invasion front exhibited decreased HNRNPLL expression. CONCLUSIONS: HNRNPLL is a novel metastasis suppressor of colorectal cancer, and modulates alternative splicing of CD44 during EMT.
引用
- Sakuma K, Sasaki E, Kimura K, et al. HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition. Gut. 2017. PMID: 28360095. doi:10.1136/gutjnl-2016-312927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。